Literature DB >> 24189845

The *1244 A>G polymorphism of MyD88 (rs7744) is closely associated with susceptibility to ulcerative colitis.

Kazuhiro Matsunaga1, Tomomitsu Tahara, Hisakazu Shiroeda, Toshimi Otsuka, Masakatsu Nakamura, Takeo Shimasaki, Nobuyuki Toshikuni, Natsuko Kawada, Tomoyuki Shibata, Tomiyasu Arisawa.   

Abstract

Toll‑like receptor activation intitially recruits the myeloid differentiation primary response gene (88) (MyD88) protein. A polymorphism *1244 A>G (rs7744) in the 3'‑untranslated region of MyD88 has been identified. In the present study, the association of this polymorphism with ulcerative colitis (UC) was investigated. The population studied comprised 922 individuals, including patients with UC (UC cases) and without (controls). Genotyping of rs7744 was performed by PCR single-strand conformation polymorphism and the rs7744 G allele frequencies in the controls and UC cases were 32.8 and 43.5%, respectively (P<0.0001). The results showed that the genotype frequency of the AA homozygote was significantly lower and that of the GG homozygote was significantly higher in the UC cases compared with those in the controls (P=0.0012 for both groups). The rs7744 minor allele variants were significantly associated with susceptibility to UC as indicated by dominant and recessive genetic models. The minor allele variants were associated with an increased risk for UC in the male individuals but not the female individuals. The rs7744 was also associated with a non‑continuous phenotype of UC and steroid unused/independent UC. This minor allele homozygote was associated with the disease severity of UC, hospitalization and response to steroid treatment. The results of the present study provided evidence that MyD88 polymorphism rs7744 was significantly associated with the development of UC and that this polymorphism may be associated with the response to treatment therapies for UC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24189845     DOI: 10.3892/mmr.2013.1769

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  4 in total

1.  Evidence of activation of the Toll-like receptor-4 proinflammatory pathway in patients with schizophrenia.

Authors:  Borja García-Bueno; Patricia Gassó; Karina S MacDowell; Luis F Callado; Sergi Mas; Miguel Bernardo; Amalia Lafuente; J Javier Meana; Juan C Leza
Journal:  J Psychiatry Neurosci       Date:  2016-04       Impact factor: 6.186

2.  A Bioinformatics Approach to Prioritize Single Nucleotide Polymorphisms in TLRs Signaling Pathway Genes.

Authors:  Behnam Alipoor; Hamid Ghaedi; Mir Davood Omrani; Milad Bastami; Reza Meshkani; Taghi Golmohammadi
Journal:  Int J Mol Cell Med       Date:  2016-05-01

3.  Two Genetic Variations in the IRF8 region are associated with Behçet's disease in Han Chinese.

Authors:  Yanni Jiang; Hong Wang; Hongsong Yu; Lin Li; Dengfeng Xu; Shengping Hou; Aize Kijlstra; Peizeng Yang
Journal:  Sci Rep       Date:  2016-01-22       Impact factor: 4.379

4.  Myeloid differentiation primary response gene (MyD) 88 signalling is not essential for intestinal fibrosis development.

Authors:  C Lutz; B Weder; A Hünerwadel; S Fagagnini; B Lang; N Beerenwinkel; J B Rossel; G Rogler; B Misselwitz; M Hausmann
Journal:  Sci Rep       Date:  2017-12-15       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.